Protein composition, adhesion, and agglutination properties of saliva in burning mouth syndrome

Tammiala‐Salonen, Tuulikki; Söderling, Eva

doi:10.1111/j.1600-0722.1993.tb01107.x

Cited by 22 publications

(24 citation statements)

References 10 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…11 The most commonly reported range has been 0.7% to 4.6% 11 , however, rates as high as 14.8% have also been estimated. 18 In present study we found 1.2% prevalence.…”

Section: Discussionsupporting

confidence: 51%

Prevalence of burning mouth syndrome in adult Turkish population

Çolak¹

2011

Dicle Med J

View full text Add to dashboard Cite

ÖZETAmaç: Ağız yanması sendromu (AYS) kronik bir orofasiyal ağrı olarak tanımlanır ve semptomatik olarak dilde ve dudakta veya bütün ağız boşluğu içinde yangı tarzında bir ağrıyla karakterizedir. Uluslararası çalışmalarda Ağız yanması sendromunun prevalansının %0,6 ile %15 arasında değiştiği rapor edilmektedir. Bu çalışmada Türk toplumunda AYS prevalansının belirlenmesi amaçlanmıştır.

show abstract

“…11 The most commonly reported range has been 0.7% to 4.6% 11 , however, rates as high as 14.8% have also been estimated. 18 In present study we found 1.2% prevalence.…”

Section: Discussionsupporting

confidence: 51%

Prevalence of burning mouth syndrome in adult Turkish population

Çolak¹

2011

Dicle Med J

View full text Add to dashboard Cite

show abstract

“…Magnesium level did not change in the saliva stimulated in patients with BMS. Tammiala‐Salonen and Soderling (1993) found no decrease in protecting and lubricating properties of saliva in patients with BMS, although they did find significantly lower total protein concentration in the stimulated saliva of women with BMS as well as higher concentration of sialic acid. Lundy et al (1997) could not find any difference in the major parotid glycoproteins between patients with BMS and controls.…”

Section: Discussionmentioning

confidence: 77%

Salivary interleukin‐6 and tumor necrosis factor‐α in patients with burning mouth syndrome

et al. 2006

View full text Add to dashboard Cite

Burning mouth syndrome (BMS) is characterized by burning symptoms on the clinically healthy oral mucosa. To date, etiology of BMS is still unknown. We hypothesized that maybe inflammation which is not clinically apparent might lead to burning symptoms which would then result in altered cytokine profile. In the 28 female patients with BMS (age range 48-80 years, mean 64.05 years) and 28 female controls (age range 40-75 years, mean 63.82 years) by use of enzyme-linked immunosorbent assay, interleukin-6 (IL-6) and tumor necrosis factor-alpha (TNF-alpha) levels were determined. Statistical analysis included use of independent sample t-test and P < 0.05 was considered as significant. Our results show no significant differences between patients and controls regarding salivary IL-6 and TNF-alpha.

show abstract

“…One study demonstrated a reduction in postmenopausal parotid flow rate (resting and stimulated); 55 another study found no differences in resting saliva in postmenopausal patients with burning tongues and those without 56 . Yet, another study investigated resting and stimulated whole saliva and parotid saliva in pre‐ and postmenopausal women and in men with BMS and matched controls 57 . Women with BMS had slightly, but not significantly, higher flow rates than their controls.…”

Section: Etiology and Pathogenesismentioning

confidence: 99%

Burning Mouth Syndrome: Will Better Understanding Yield Better Management?

Maltsman-Tseikhin

Moricca²,

Niv

2007

Pain Practice

View full text Add to dashboard Cite

"Burning mouth syndrome" (BMS) refers to a chronic orofacial pain disorder usually unaccompanied by mucosal lesions or other clinical signs of organic disease. BMS is typically characterized by a continuous, spontaneous, and often intense burning sensation as if the mouth or tongue were scalded or on fire. Burning mouth syndrome is a relatively common condition. The estimated prevalence of BMS reported in recent studies ranges between 0.7 and 4.6% of the general population. About 1.3 million American adults, mostly women in the postmenopausal period, are afflicted with BMS. The etiology of this disorder is poorly understood even though new evidence for a possible neuropathic pathogenesis of idiopathic BMS is emerging. Burning mouth syndrome may present as an idiopathic condition (primary BMS type) distinct from the symptom of oral burning that can potentially arise from various local or systemic abnormalities (secondary BMS type), including nutritional deficiencies, hormonal changes associated with menopause, local oral infections, denture-related lesions, xerostomia, hypersensitivity reactions, medications, and systemic diseases including diabetes mellitus. In more than a third of patients, multiple, concurrent causes of BMS may be identified. It is important to note that the diagnosis of BMS should be established only after all other possible causes have been ruled out. Professional delay in diagnosing, referring, and appropriately managing of BMS patients occurs frequently. Treatment should be tailored to each patient and it is recommended to practice the treatment in a multidisciplinary facility. This article discusses our current understanding of the etiology and pathogenesis of BMS. The authors have tried to emphasize new pharmacological approaches to manage this challenging disorder.

show abstract

Protein composition, adhesion, and agglutination properties of saliva in burning mouth syndrome

Cited by 22 publications

References 10 publications

Prevalence of burning mouth syndrome in adult Turkish population

Prevalence of burning mouth syndrome in adult Turkish population

Salivary interleukin‐6 and tumor necrosis factor‐α in patients with burning mouth syndrome

Burning Mouth Syndrome: Will Better Understanding Yield Better Management?

Contact Info

Product

Resources

About